Global healthcare partner Costello Medical is an award-winning, independent global healthcare agency specializing in Medical Communications and HEOR, serving pharmaceutical and MedTech clients across Europe, US, Canada, and Asia Pacific. Opportunity: pursue multi-region, integrated evidence development and market access programs for pharma teams expanding international footprints.

Pro bono as value The firm delivers extensive pro bono support to charities and non-profits, signaling a strong value-driven brand and the potential to partner on patient advocacy and real-world evidence initiatives. Opportunity: propose joint value projects with patient groups and health policy organizations to showcase impact while expanding service offerings.

Award winning traction Recognized with Best Companies accreditation, B Corp certification, King’s Award for Enterprise in International Trade, and PMi Agency of the Year honors, indicating high credibility and growth momentum. Opportunity: leverage distinguished credentials to engage enterprise customers seeking governance, sustainability, and international trade expertise in health tech and rare disease spaces.

Rare diseases focus Dedicated teams for Rare Diseases and MedTech, with capabilities in evidence development, HTA, and patient engagement. Opportunity: target orphan drugs, diagnostics, and digital health platforms requiring robust HEOR, REAL-World Evidence, and market access support to maximize reimbursement success.

Expansion potential Recent notable activity includes collaborations, industry events, and expansion of offices, plus a sizable revenue base in the hundreds of millions. Opportunity: present scalable, end-to-end engagement models for large pharma pipelines, including statistical analysis, publications, policy advocacy, and digital health tool integration.